Investment
Features
FeesSafety
Academy
More
Pluang+

Compare DCI Indonesia Tbk (DCII) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance

DCI Indonesia TbkTrade
Tempo Scan Pacific Tbk.Trade

Price performance (Past 24H)

Key statistics

DCI Indonesia Tbk vs Tempo Scan Pacific Tbk. — how do they compare? DCI Indonesia Tbk trades at Rp198,675 (market cap 473.71T, 1K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,520 (market cap 11.18T, 613K 24h volume). The key difference: DCI Indonesia Tbk is far larger — about 42.4× Tempo Scan Pacific Tbk.'s market cap, and Tempo Scan Pacific Tbk. is more actively traded (613K versus 1K). Which is the better fit depends on your goals.

DCIITSPC
Market Cap
473.71T11.18T
Volume
1K613K
Lot
106.13K
Turnover
194.12M1.54B
Average Price
194,1202,511.52
Value
194.12M1.54B
Indicative Equilibrium Price
199,0002,520
Indicative Equilibrium Volume
117

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DCII
View details
TSPC
View details

About DCI Indonesia Tbk

PT DCI Indonesia Tbk (the Company) was established in Indonesia based on Notarial Deed No. 143 of Buntario Tigris, S.H., S.E., M.H., on July 18, 2011. The Company started its commercial operations in 2013. The Company parent entity and ultimate controlling party is DCI International Holding Pte. Ltd., Singapore.

Read more on DCII

About Tempo Scan Pacific Tbk.

PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.

Read more on TSPC